A differential association of ALOX15 polymorphisms with bone mineral density in pre- and post-menopausal women

Hum Hered. 2008;65(1):1-8. doi: 10.1159/000106057. Epub 2007 Jul 25.

Abstract

Objective: The 12/15-lipoxygenase gene ALOX15 is reported to be a negative regulator of BMD in knockout mice. Nonetheless results are controversial as over-expression of ALOX15 protects against inflammation-related bone loss. The aim of the present study is to systematically study the relation of ALOX15 polymorphisms in BMD variation in southern Chinese women.

Methods: Ten tag single nucleotide polymorphisms (SNP) were genotyped in 942 subjects with either low BMD (defined by a BMD Z score < or =-1.28 at either the hip or spine) or high BMD (Z score > or =+1). Single locus and haplotype associations were performed using logistic regression with adjustment of age, height and weight.

Results: The variant 'G' allele of rs2619112 was associated with a reduced risk of low BMD at the femoral neck in pre-menopausal women (OR = 0.442, p = 0.007) but an increased risk in post-menopausal women (OR = 1.727, p = 0.042). Haplotype analysis revealed findings similar to the single locus tests.

Conclusion: The variant alleles of rs2619112 and rs916055 and their haplotypes of ALOX15 are associated with high BMD in pre-menopausal women but low BMD in post-menopausal women. This suggests that ALOX15 is a dual modulator of BMD variation with opposing effects in pre- and post-menopausal women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Arachidonate 15-Lipoxygenase / genetics*
  • Bone Density / genetics*
  • Chromosomes, Human, Pair 17
  • Female
  • Haplotypes
  • Humans
  • Linkage Disequilibrium
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Postmenopause*
  • Premenopause*

Substances

  • ALOX15 protein, human
  • Arachidonate 15-Lipoxygenase